HMGA1-pseudogene overexpression contributes to cancer progression

Cell Cycle

Volumn 13, Issue 23, 2014, Pages 3636-3639

  Esposito, Francesco ^a   De Martino, Marco ^a   Forzati, Floriana ^a   Fusco, Alfredo ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A1A PROTEIN; MICRORNA; RNA; SMALL INTERFERING RNA; UNTRANSLATED RNA; HIGH MOBILITY GROUP A PROTEIN;

BASE PAIRING; CANCER GROWTH; CARCINOGENESIS; CHROMATIN; DIFFERENTIATED THYROID CANCER; DNA STRAND; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; MULTIGENE FAMILY; PSEUDOGENE; REVIEW; RNA STABILITY; RNA TRANSLATION; THYROID CARCINOMA; THYROID CELL; UNTRANSLATED REGION; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL PROLIFERATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGA PROTEINS; HUMANS; MICRORNAS; NEOPLASMS; PSEUDOGENES;

EID: 84920620851     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.974440     Document Type: Review

References (27)

1. Furuno M, Pang KC, Ninomiya N, Fukuda S, Frith MC, Bult C, Kai C, Kawai J, Carninci P, Hayashizaki Y, et al. Clusters of Internally Primed Transcripts Reveal Novel Long Noncoding RNAs. PLoS Genet 2006; 2:e37; PMID:16683026; http://dx.doi.org/ 10.1371/journal.pgen.0020037
2. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136:629-41; PMID:19239885; http://dx.doi.org/ 10.1016/j.cell.2009.02.006
3. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 2001; 293: 1146-50; PMID:11498593; http://dx.doi.org/10.1126/ science.1064023
4. Zhang Y, Li J, Kong L, Gao G, Liu QR, Wei L. NATsDB: Natural Antisense Transcripts DataBase. Nucl Acids Res 2007; 35:D156-61; PMID:17082204; http://dx.doi.org/10.1093/nar/gkl782
5. Zeng Y, Yi R, Cullen BR. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci U S A 2003; 100:9779-84; PMID:12902540; http://dx.doi.org/ 10.1073/pnas.1630797100
6. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol 2004; 2:e363; PMID:15502875; http://dx.doi.org/ 10.1371/journal.pbio.0020363
7. Krek A, Gr€un D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37:495-500; PMID:15806104; http://dx.doi.org/10.1038/ng1536
8. Kornienko AE, Guenzl PM, Barlow DP, Pauler FM. Gene regulation by the act of long non-coding RNA transcription. BMC Biol 2013; 11:59; PMID:23721193; http://dx.doi.org/10.1186/1741-7007-11-59
9. Mighell AJ, Smith NR, Robinson PA, Markham AF. Vertebrate pseudogenes. FEBS Lett 2000; 468:109-14; PMID:10692568; http://dx.doi.org/10.1016/S0014-5793 (00)01199-6
10. Harrison PM, Hegyi H, Balasubramanian S, Luscombe NM, Bertone P, Echols N, Johnson T, Gerstein M. Molecular fossils in the human genome: Identification and analysis of the pseudogenes in chromosomes 21 and 22. Genome Res 2002; 12:272-80; PMID:11827946; http://dx.doi.org/10.1101/gr.207102
11. Balakirev ES, Ayala FJ. Pseudogenes: Are they "junk" or functional DNA? Annu Rev Genet 2003; 37:123-51; PMID:14616058; http://dx.doi.org/10.1146/annurev. genet.37.040103.103949
12. Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010; 465:1033-38; PMID:20577206; http://dx.doi.org/10.1038/nature09144
13. Zhang ZD, Frankish A, Hunt T, Harrow J, Gerstein M. Identification and analysis of unitary pseudogenes: historic and contemporary gene losses in humans and other primates. Genome Biol 2010; 11:R26; PMID:20210993; http://dx.doi.org/10.1186/gb-2010-11-3-r26
14. Esposito F, De Martino M, Petti MG, Forzati F, Tornincasa M, Federico A, Arra C, Pierantoni GM, Fusco A. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs. Oncotarget 2014; 5:8344-54; PMID:25268743.
15. Fusco A, Fedele M. Roles of the HMGA proteins in cancer. Nat Rev Cancer 2007; 7:899-910; PMID:18004397; http://dx.doi.org/10.1038/ nrc2271
16. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai BM, Fidanza V, Giancotti V, Santoro M, et al. High level expression of the HMGA1 gene during embryonic development. Oncogene 1996; 13:2439-46; PMID: 8957086
17. Piscuoglio S, Zlobec I, Pallante P, Sepe R, Esposito F, Zimmermann A, Diamantis I, Terracciano L, Fusco A, Karamitopoulou E. HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma. Histopathology 2012; 60:397-404; PMID:22276603; http://dx.doi.org/10.1111/j.1365-2559.2011.04121.x
18. Pegoraro S, Ros G, Piazza S, Sommaggio R, Ciani Y, Rosato A, Sgarra R, Del Sal G, Manfioletti G. HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness. Oncotarget 2013; 4:1293-1308; PMID:23945276
19. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 1995; 15:1545-53; PMID:7862147
20. Berlingieri MT, Pierantoni GM, Giancotti V, Santoro M, Fusco A. Thyroid cell transformation requires the expression of the HMG1 proteins. Oncogene 2002; 21:2971-80; PMID:12082527; http://dx.doi.org/10.1038/sj.onc.1205368
21. Scala S, Portella G, Fedele M, Chiappetta G, Fusco A. Adenovirus mediated suppression of the HMGI(Y) protein synthesis as a potential therapy of human malignant neoplasias. Proc Natl Acad Sci USA. 2000; 97:4256-61; http://dx.doi.org/10.1073/pnas.070029997
22. Vallone D, Battista S, Pierantoni GM, Fedele M, Casalino L, Santoro M, Viglietto G, Fusco A, Verde P. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J 1997; 16:5310-21; PMID:9311991; http://dx.doi.org/10.1093/emboj/ 16.17.5310
23. Palmieri D, Valentino T, De Martino I, Esposito F, Cappabianca P, Wierinckx A, Vitiello M, Lombardi G, Colao A, Trouillas J, et al. PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. Endocr Relat Cancer 2012; 19:123-35; PMID:22199144; http://dx.doi.org/10.1530/ERC-11-0135
24. Fedele M, Pentimalli F, Baldassarre G, Battista S, Klein-Szanto AJ, Kenyon L, Visone R, De Martino I, Ciarmiello A, Arra C, et al. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 2005; 24:3427-35; PMID:15735694; http://dx.doi. org/10.1038/sj.onc.1208501
25. Borbone E, Troncone G, Ferraro A, Jasencakova Z, Stojic L, Esposito F, Horning N, Fusco A, Orlando V. Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas. J Clin Endocrinol Metab 2011; 96:1029-38; PMID:21289264; http://dx.doi.org/10.1210/jc.2010-1784
26. Esposito F, Tornincasa M, Pallante P, Federico A, Borbone E, Pierantoni GM, Fusco A. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J Clin Endocrinol Metab 2012; 97:E710-8; PMID:22399519; http://dx.doi.org/ 10.1210/jc.2011-3068
27. Kumar MS, Armenteros-Monterroso E, East P, Chakravorty P, Matthews N, Winslow MM. HMGA2 functions as a competing endogenous RNA to promote lung cancer progression. Nature 2014; 505:212-17; PMID:24305048; http://dx.doi.org/10.1038/nature12785